SCHEMBL14640873

SCHEMBL14640873

O=C1c2cc(CO)c(CO)cc2CC1CC1CCN(Cc2cccc3ccccc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.57
BCHE P06276 11/20 0.56
FAAH O00519 1/20 0.52
ABCC4 O15439 1/20 0.52
CACNA1F O60840 1/20 0.52
PDE5A O76074 1/20 0.52
ABCB11 O95342 1/20 0.52
APP P05067 1/20 0.52
CHRM2 P08172 1/20 0.52
ABCB1 P08183 1/20 0.52
CYP3A4 P08684 1/20 0.52
CHRM5 P08912 1/20 0.52
ADRA2A P08913 1/20 0.52
CHRM1 P11229 1/20 0.52
ADRA2C P18825 1/20 0.52
DRD4 P21917 1/20 0.52
SLC6A2 P23975 1/20 0.52
MAOB P27338 1/20 0.52
AGTR1 P30556 1/20 0.52
ADRA1A P35348 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678139 0.86 BCHE (0.69) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL676837 0.86 BCHE (0.69) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL6867659 0.86 BCHE (0.69) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL676836 0.86 BCHE (0.69) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL14640874 0.86 BCHE (0.56) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL14601853 0.85 ACHE (0.79) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL12808576 0.81 ACHE (0.70) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL6584528 0.80 ACHE (0.80) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL8281051 0.80 BCHE (0.66) ACHEBCHEFAAHABCC4CACNA1F
SCHEMBL14640877 0.78 ACHE (0.68) ACHEBCHEFAAHABCC4CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021397-A1 Neurocyte protective agent EISAI CO., LTD. (JP) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021397-A1 Neurocyte protective agent CHAT, GAP43, NES ACHE 6/4885BCHE 26/4885FAAH 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.